MedPath

Nobias Therapeutics, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

Phase 2
Completed
Conditions
22q11 Deletion Syndrome
Interventions
Other: Placebo
First Posted Date
2022-03-22
Last Posted Date
2025-02-10
Lead Sponsor
Nobias Therapeutics, Inc.
Target Recruit Count
37
Registration Number
NCT05290493
Locations
🇨🇦

The Hospital for Sick Children (SickKids), Toronto, Ontario, Canada

🇺🇸

Children's Hospital Colorado, Aurora, Colorado, United States

🇺🇸

Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania, United States

and more 1 locations
© Copyright 2025. All Rights Reserved by MedPath